Treatment of idiopathic restless legs syndrome (RLS) with slow-release valproic acid compared with slow-release levodopa/benserazid: A randomized, placebo-controlled, double-blind, cross-over study

Journal of Neurology

Volumn 251, Issue 5, 2004, Pages 579-583

  Eisensehr, Ilonka ^a   Ehrenberg, Bruce L ^b   Solti, Silvia Rogge ^a   Noachtar, Soheyl ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Polysomnography; Restless legs syndrome; Valproic acid

Indexed keywords

BENSERAZIDE; LEVODOPA; PLACEBO; VALPROIC ACID;

ADULT; AGED; AROUSAL; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG RELEASE; FEMALE; HUMAN; MALE; PARESTHESIA; POLYSOMNOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESTLESS LEGS SYNDROME; SLEEP DISORDER;

ADULT; AGED; ANTICONVULSANTS; ANTIPARKINSON AGENTS; BENSERAZIDE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEVODOPA; MALE; MIDDLE AGED; POLYSOMNOGRAPHY; QUESTIONNAIRES; RESTLESS LEGS SYNDROME; TIME FACTORS; TREATMENT OUTCOME; VALPROIC ACID;

EID: 2542450239     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00415-004-0367-6     Document Type: Article

References (10)

1. Allen RP, Barley CJ (1996) Augmentation of the restless legs syndrome with carbidopa/levo-dopa. Sleep 19:205-2013
2. Ambrosetto C, Lugaresi E, Coccagna G, Tassinari CA (1965) Clinical and polygraphic remarks in the restless legs syndrome. Riv Patol Nerv Ment 86:244-251
3. Chapman A, Keane PE, Meldrum BS, Simiand J, Vernieres JC (1982) Mechanism of anticonvulsant action of valproate. Progr Neurobiol 19:15-359
4. Comella CL (2002) Restless legs syndrome: Treatment with dopaminergic agents. Neurology 58:87-92
5. Ehrenberg BL, Eisensehr I, Corbett KE, Crowley PF, Walters AS (2000) Valproate for sleep consolidation in periodic limb movement disorder. J Clin Psychopharmacol 20:574-578
6. Eisensehr I, Ehrenberg BL, Noachtar S, Korbett K, Byrne A, McAuley A, Palabrica T (1998) Platelet activation, epinephrine, and blood pressure in obstructive sleep apnea syndrome. Neurology 51:188-195
7. Henning W, Allen R, Early C, Kushida C, Picchetti D, Silber M (1999) Treatment of restless legs syndrome and periodic limb movement disorder. An American Academy of Sleep Medicine review. Sleep 22:970-999
8. Montplaisir J, Boucher S, Gosselin A, Poirier G, Lavigne G (1996) Persistence of repetitive EEG arousals (K-alpha complexes) in RLS patients treated with L-DOPA. Sleep 19:196-199
9. Trenkwalder C, Stiasny K, Pollmacher T, Wetter T, Schwarz J, Kohnen R, Kazenwadel J, Kruger HP, Ramm S, Kunzel M, et al. (1995) L-dopa therapy of uremic and idiopathic restless legs syndrome: a double-blind, crossover trial. Sleep 18:681-688
10. Walters AS (1995) Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group. Mov Disord 10:634-642